Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 7, 2015, Pages 783-789

  Shariff, Nasir ^a   Eby, Elizabeth ^b   Adelstein, Evan ^a   Jain, Sandeep ^a   Shalaby, Alaa ^c   Saba, Samir ^a   Wang, Norman C ^a   Schwartzman, David ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b MEDTRONIC INC   (United States)

^c Veterans Administration   (United States)

Author keywords

antibiotic; cardiac implantable electronic device; cardiac resynchronization therapy; defibrillator; infection; pacemaker

Indexed keywords

CEFALEXIN; CEFAZOLIN; CLINDAMYCIN; VANCOMYCIN;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CARDIAC IMPLANT; CARDIAC IMPLANTED ELECTRICAL DEVICE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEVICE INFECTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL MESH; TREATMENT DURATION; ADVERSE EFFECTS; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COST BENEFIT ANALYSIS; ECONOMICS; EQUIPMENT CONTAMINATION; HEALTH SERVICES RESEARCH; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LENGTH OF STAY; MICROBIOLOGY; MIDDLE AGED; PROSTHESIS; PROSTHESIS-RELATED INFECTIONS; TERTIARY CARE CENTER; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT CONTAMINATION; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PENNSYLVANIA; PROCESS ASSESSMENT (HEALTH CARE); PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; STANDARD OF CARE; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84948566192     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12684     Document Type: Article

References (22)

1. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA III, Gewitz M, Newburger JW, Schron EB, Taubert KA,: Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458-477.
2. Tarakji KG, Wilkoff BL,: Management of cardiac implantable electronic device infections: The challenges of understanding the scope of the problem and its associated mortality. Expert Rev Cardiovasc Ther 2013; 11: 607-616.
3. Kolek MJ, Dresen WF, Well QS, Ellis CR,: Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol 2013; 36: 354-361.
4. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ,: Mortality and cost associated with cardiovascular electronic device infections. Arch Intern Med 2011; 171: 1821-1828.
5. Bloom HL, Constantin L, Dan D, DeLurgio DB, El-Chami M, Ganz LI, Gleed KJ, Hackett FK, Kanuru NK, Lerner DL, Rasekh A, Simons GR, Sogade FO, Sohail MR, for the COMMAND investigators: Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 2011; 34: 133-142.
6. Hansen LK, Brown M, Johnson D, Palme Li DF, Love C, Darouiche R,: In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices. Pacing Clin Electrophysiol 2009; 32: 898-907.
7. Mittal S, Shaw RE, Michel K, Palekar R, Arshad A, Musat D, Preminger M, Sichrovsky T, Steinberg JS,: Cardiac implantable electronic device infections: Incidence, risk factors, and the effect of the AIGISRx antibacterial envelope. Heart Rhythm 2014; 11: 595-601.
8. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastein B, Kacet S, PEOPLE Study Group: Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116: 1349-1355.
9. Prutkin JM, Reynolds MR, Bao H, Curtis JP, Al-Khatib SM, Aggarwal S, Uslan DZ,: Rates and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: Results from the National Cardiovascular Data Registry. Circulation 2014; 130: 1037-1043.
10. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET, Bootsma M, Zeppenfeld K, Jukema JW, Borleffs JW, Schalij MJ, van Erven L,: Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009; 95: 715-720.
11. Gould PA, Krahn AD, Canadian Heart Rhythm Society Working Group on Device Advisories: Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006; 295: 1907-1911.
12. Le KY, Sohail MR, Friedman PA, Uslan DZ, Cha SS, Hayes DL, Wilson WR, Steckelberg JM, Baddour LM, Mayo Cardiovascular Infections Study Group: Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol 2011; 34: 450-459.
13. Nagpal A, Baddour LM, Sohail MR,: Microbiology and pathogenesis of cardiovascular implantable electronic device infections. Circ Arrhythm Electrophysiol 2012; 5: 433-441.
14. Report to Congress: Medicare and the Health Care Delivery System. Chapter 6; http://www.medpac.gov/chapters/Jun12-Ch06-APPENDIX.pdf (Accessed June 2012).
15. Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Revised Fee Schedule. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/DMEPOSFeeSched/index.html.
16. Austin PC,: Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004-2006: A systematic review. Circ Cardiovasc Qual Outcomes 2008; 1: 62-67.
17. Stuart EA, Ho D, Imai K, King G,: MatchIt: Nonparametric preprocessing for parametric causal reference. J Stat Softw 2011; 42: 1-28.
18. Greenspon AJ, Prutkin JM, Sohail MR, Vikram HR, Baddour LM, Danik SB, Peacock J, Falces C, Miro JM, Blank E, Naber C, Carillo RG, Tseng CH, Uslan DZ,: Timing of the most recent procedure influences the clinical outcome of lead-associated endocarditis. Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol 2012; 59: 681-687.
19. Henrikson CA, Sohail MR, Simons GR, Lerner DJ,: CITADEL/CENTURION study results: Use of an antibacterial envelope is associated with very low 6 month CIED infection rates. Europace 2014; 16: ii156.
20. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ,: Increased long-term mortality in patients with cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol 2015; 38: 231-239.
21. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Ciller SD, Simon AW,: The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 2006; 47: 2493-2497.
22. Ferguson TB, Ferguson CL, Crites K, Crimmons-Reda P,: The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg 1996; 111: 742-752.